Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

98 trials with published results (11%)

Research Maturity

572 completed trials (64% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.9%

53 terminated out of 898 trials

Success Rate

91.5%

+5.0% vs benchmark

Late-Stage Pipeline

19%

171 trials in Phase 3/4

Results Transparency

17%

98 of 572 completed with results

Key Signals

98 with results92% success53 terminated

Data Visualizations

Phase Distribution

519Total
Not Applicable (215)
Early P 1 (9)
P 1 (51)
P 2 (73)
P 3 (59)
P 4 (112)

Trial Status

Completed572
Unknown144
Recruiting63
Terminated53
Active Not Recruiting26
Withdrawn21

Trial Success Rate

91.5%

Benchmark: 86.5%

Based on 572 completed trials

Clinical Trials (898)

Showing 20 of 20 trials
NCT07448038Phase 2RecruitingPrimary

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

NCT07613294Phase 3RecruitingPrimary

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

NCT01399385Not ApplicableRecruiting

New Heart Imaging Techniques to Evaluate Possible Heart Disease

NCT07719894Phase 4Recruiting

Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes

NCT06590012Phase 2Active Not RecruitingPrimary

SIALIDASE INHIBITION AS ANTIATHEROSCLEROTIC THERAPY

NCT00353782Recruiting

Causes and Natural History of Dyslipidemias

NCT01143480Recruiting

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

NCT06692127Active Not RecruitingPrimary

DETECTion of the Prevalence of Silent Atherosclerosis Across Adult Life - Phase I of REACT

NCT01143454Recruiting

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

NCT07521007Phase 2Not Yet RecruitingPrimary

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

NCT07693712Terminated

Senescence in Myocardial Infarction

NCT06013722Not ApplicableActive Not RecruitingPrimary

Strategy for Unstable Coronary Plaque in Patients Presenting to Emergency Department for Chest Pain Suspected of Coronary Artery Disease

NCT05906797Not ApplicableCompletedPrimary

Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Periodontitis.

NCT07625488Enrolling By Invitation

Measuring Athlete's Risk of Cardiovascular Events 3 (MARC-3)

NCT02991703Not ApplicableCompleted

Simplified Pulse Wave Velocity Measurement, Validation Study of the pOpmètre in Children

NCT07524101Not ApplicableRecruiting

Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD

NCT05994014Not ApplicableRecruiting

PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]

NCT05867381Not ApplicableRecruiting

Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History

NCT04167761Early Phase 1Completed

Ertugliflozin: Cardioprotective Effects on Epicardial Fat

NCT04496947Not ApplicableRecruitingPrimary

Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study

Scroll to load more

Research Network

Activity Timeline